This abstract was accepted for publication only, and published in the supplement of HemaSphere (pages 6153-6154)

Link to Publication-Only Abstract
 

Publication
  • EHA •
  • 14 June, 2024 •
  • •

A Phase 3, Randomised, Double-Blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Thrombocytopenia in Paediatric Subjects with Immune Thrombocytopenia (AVA-PED-301)

Rachael F. Grace, Göksel Leblebisatan, Yesim Aydinok, Şule Ünal, John Grainger, Jessica Zhang, Linda Smallwood, Emily de León, Brian D. Jamieson

Available materials

Oral Presentation
Publication
  • EHA •
  • 14 June, 2024 •
  • •

Real-World Treatment Patterns and Outcomes in Patients with Immune Thrombocytopenia Treated with Avatrombopag in the United States: REAL-AVA 2.0 Interim Analysis Results

Srikanth Nagalla, My Levy, Shruti Chaturvedi, Abiola Oladapo, Chelsea Bernheisel, Elyse Swallow, Debbie Goldschmidt, Alexandra Greatsinger, Kirthana Sarathy, Loren Ormenaj, Michael Vredenburg , Scott Kolodny

Publication
  • EHA •
  • 14 June, 2024 •
  • •

A European retrospective study to describe real-world outcomes, treatment patterns and resource use in primary idiopathic thrombocytopenic purpura patients treated with avatrombopag: Interim results

Francesco Zaja, Quentin Hill, Fiona Glen, Fatemeh Saberi Hosnijeh, Luca Le Treust, Lara Groves, Milica Putnik, Carly Rich

Publication
  • JSH •
  • 10 October, 2025 •
  • •

One-year efficacy and safety of avatrombopag for chronic immune thrombocytopenia in Japanese adults

Hiroki Yamaguchi, Masaki Iino, Yoshiaki Tomiyama , Harumi Kamiya, Jessica Zhang, Nina Skuban

Publication
  • ISTH •
  • 24 June, 2025 •
  • •

Analysis of Baseline Influences on Platelet Response to Avatrombopag (AVA) from a Phase 3b Multicenter, Randomized, Double-Blind, Placebo (PBO)-controlled, Parallel-group Trial to Evaluate the Efficacy and Safety of AVA for the Treatment of Pediatric Pati

Rachael F. Grace, Göksel Leblebisatan, Yesim Aydinok, Şule Ünal, John Grainger, Amanda Grimes, Michele Lambert, Jessica Zhang, Brian D. Jamieson, Michael Vredenburg , Scott Kolodny

Available materials

Poster
Publication
  • ISTH •
  • 24 June, 2025 •
  • •

Real-World Outcomes of Avatrombopag Treatment in Primary ITP Stratified by Prior TPO-RA Exposure

Srikanth Nagalla, Moshe Y Levy, Shruti Chaturvedi, Scott Kolodny, Abiola Oladapo, Chelsea Bernheisel, Elyse Swallow, Debbie Goldschmidt, Alexandra Greatsinger, Loren Ormenaj, Sinia Sareen, Michael Vredenburg

Available materials

Oral Presentation
Publication
  • ISTH •
  • 22 June, 2025 •
  • •

Evaluation of Efficacy and Safety of Avatrombopag in Children with ITP Based on Disease Duration

Rachael F. Grace, Göksel Leblebisatan, Yesim Aydinok, Şule Ünal, John Grainger, Amanda Grimes, Michele Lambert, Jessica Zhang, Brian Jamieson, Michael Vredenburg , Scott Kolodny

Available materials

Poster
Sign up for alerts